Print

Fibrocell Science, Inc. Announces Exclusive License Agreement with University of California, Los Angeles (UCLA) on Dermal Cell Research to Advance the Development of Personalized Cell Therapies  
5/16/2012 10:13:33 AM

EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc. (OTCBB: FCSC) announced today that it has signed an exclusive license agreement with The Regents of the University of California, under which it acquired the rights to commercially apply discoveries resulting from the scientific collaboration between the University of California, Los Angeles (UCLA) and Fibrocell Science, Inc. This is the second collaboration between Fibrocell Science and UCLA. As part of the existing agreement, using Fibrocell Science’s proprietary technology, UCLA researchers discovered rare stem cells and cell types with regenerative properties within adult human skin. These breakthrough research findings were recently published in the inaugural issue of BioResearch Open Access (May 2, 2012). The new license agreement sets the stage for the continuation of the collaboration and the development of future clinical research programs that may lead to new personalized therapies or diagnostic tools for a variety of diseases and conditions.